FFundraiseJet
ARCH Venture Partners logo

ARCH Venture Partners

Chicago, Illinois · Invests in US; North America; Europe; Asia · Website

Check size

🔒 $•• – $••
+ Save to my list
SeedSeries APre-SeedAI & Machine LearningDeveloper ToolsHealthcare & BiotechHardware & DevicesBiotech & Life SciencesHealthcare & Digital HealthDeveloper Tools & Infrastructure

Thesis

Co-found and build breakthrough life sciences and deep-science companies with university researchers. Follow science to create revolutionary technologies that prevent, detect, and cure disease. Patient capital from concept stage through commercialization.

Likely not a fit for

Not interested in following the crowd. Avoid incremental innovation or me-too drug development without transformative science. Not suited for passive capital-seeking founders.

How they invest

Lead or follow
Usually leads
Typical decision
~2 weeks
Warm intro
Not required
Involvement
Takes a board seat
Fund status
Actively deploying
Decision process
Partnership vote

Partners & team

9 contacts on file

RN

Robert Nelsen

General PartnerCo-founder & Managing Director · Primary contact

+ Pitch

LinkedIn profile

X profile

Sign up free to unlock contact →
KC

Keith Crandell

General PartnerCo-founder & Managing Director

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
KB

Kristina Burow

PartnerManaging Director

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
SG

Steve Gillis

PartnerManaging Director

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
PB

Paul Berns

PartnerManaging Director

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
BC

Brian Cuneo

PartnerSenior Partner

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
CS

Carol Suh

PartnerPartner

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
AN

Ari Nowacek

PartnerPartner

+ Pitch

LinkedIn profile

Sign up free to unlock contact →
CR

Corey Ritter

PartnerPartner

+ Pitch

LinkedIn profile

Sign up free to unlock contact →

Portfolio

IlluminaBiotech Life Sciences

Illumina provides sequencing and array solutions to fuel genomic discoveries, offering a range of products including instruments, kits, reagents, and software for genomic research.

Juno TherapeuticsBiotech Life Sciences

Juno Therapeutics is now part of Bristol Myers Squibb, a global biopharmaceutical company focused on cancer care. The company develops new medicines through innovative research.

Agios PharmaceuticalsBiotech Life Sciences

Agios Pharmaceuticals is focused on discovering and developing innovative medicines for patients with rare diseases, particularly those related to metabolic disorders.

Alnylam PharmaceuticalsBiotech Life Sciences

Alnylam Pharmaceuticals is a leading company in the field of RNA interference (RNAi) therapeutics, focusing on the development of innovative medicines for genetic diseases.

Receptos
Vir BiotechnologyBiotech Life Sciences

Vir Biotechnology leverages the immense potential of the immune system to address critical unmet medical needs and improve patient outcomes through innovative therapeutic solutions.

Denali TherapeuticsBiotech Life Sciences

Denali Therapeutics is focused on developing therapies for neurodegenerative diseases using their proprietary TransportVehicle™ platform.

GrailBiotech Life Sciences

Grail is a healthcare company focused on multi-cancer early detection through innovative genomic technologies, including the Galleri test, which can detect over 50 types of cancers from a single blood draw.

Twist BioscienceBiotech Life Sciences

Twist Bioscience is a leader in DNA synthesis, providing innovative solutions for various applications including gene synthesis, oligo pools, and antibody discovery.

Lyell Immunopharma
Sana BiotechnologyBiotech Life Sciences

Sana Biotechnology is focused on engineered cells as medicines, aiming to repair and control genes or replace missing or damaged cells to address the underlying causes of diseases.

Scholar RockBiotech Life Sciences

Scholar Rock is a biopharmaceutical company committed to improving lives through the discovery and development of innovative medicines, focusing on treating complex diseases at their biological root.

Recent activity

ARCH Venture Partners in the news

Similar firms

Third Rock Ventures$2M–$50M

Early-stage drug-discovery company creator that originates companies in-house, incubates single ultra-orphan and rare-disease bets for years and millions, and commits to very long development timelines.

5AM Ventures$500K–$20M

5AM Ventures focuses exclusively on the earliest stages of life sciences companies, often investing at or before seed stage and operating an in-house company-creation engine called the 4:59 Initiative. The firm combines hands-on involvement with partners taking short-term operating roles and remaining deeply engaged throughout a company's life, alongside systematic focus on capital efficiency and faster realizations.

Atlas Venture$500K–$1M

Seed and early-stage investor that creates and invests in biotech startup companies, emphasizing company creation.

Axial VC$100K–$5M

Invests in early-stage life sciences companies, often backing founders when they are no more than an idea.

Breakout Ventures$250K–$15M

Bioscience investor translating grant-funded research into venture-scale companies, with a pipeline centered on engineering biology using robotic cloud labs and computational design for human health and planetary sustainability. The firm grew directly out of a philanthropic grants program at the Thiel Foundation that funded highly speculative science before spinning into a traditional venture fund.

Research briefRead more
ARCH Venture Partners Research Overview ARCH Venture Partners is one of the world's leading venture capital firms focused exclusively on early-stage, breakthrough discoveries in life sciences, deep science, and information technology. Founded in 1997 and headquartered in Chicago, Illinois, with a secondary office in Seattle, Washington, ARCH has established itself as the premier builder of transfo…

Sign up free to read the full research brief →

Add ARCH Venture Partners to your investor list

Sign up free to save investors, see partner contacts, and track your raise.

Sign up